PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 5 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,354,000 | -74.6% | 44,131 | -66.9% | 0.20% | -73.0% |
| Q2 2023 | $5,337,000 | +35.7% | 133,195 | +38.2% | 0.73% | +29.4% |
| Q1 2023 | $3,932,000 | +6.7% | 96,356 | +1.0% | 0.56% | +6.2% |
| Q4 2022 | $3,684,000 | -27.4% | 95,414 | -0.0% | 0.53% | -32.4% |
| Q3 2022 | $5,077,000 | -5.8% | 95,443 | +3.3% | 0.79% | -2.6% |
| Q2 2022 | $5,388,000 | -24.5% | 92,415 | -1.1% | 0.81% | -9.0% |
| Q1 2022 | $7,132,000 | – | 93,448 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |